TY - JOUR
T1 - Chronic dialysis in children and adolescents. The 2001 NAPRTCS annual report
AU - Neu, Alicia M.
AU - Ho, P. L.
AU - McDonald, Ruth A.
AU - Warady, Bradley A.
PY - 2002
Y1 - 2002
N2 - The 2001 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) registry includes data on 4,546 dialysis patients. Important trends in dialysis care include a significant increase in the use of peritoneal dialysis catheters with two cuffs (51.6% vs. 36.2%, P<0.001), a Swan neck tunnel (34.1% vs. 20.9%, P<0.001), and a downward pointing exit site (34.9% vs. 29.5%, P<0.001) in patients who initiated dialysis between 1997 and 2000 compared with 1992-1996. Most hemodialysis patients continued to have an external percutaneous catheter as their access at the time of initiation of dialysis (1,550/1.971 patients, 78.6%), but the odds of using a jugular rather than a subclavian vein for these catheters increased by 24% each year between 1992 and 2000. There was a significant trend for increasing use of erythropoietin and by 1996, 96% of patients were prescribed this medication at initiation of dialysis. There was also a modest, but significant, increase in hematocrit in the dialysis registry, as the median hematocrit at 6 months of follow-up was 31% in patients who started dialysis between 1997 and 2000 (P<0.001).
AB - The 2001 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) registry includes data on 4,546 dialysis patients. Important trends in dialysis care include a significant increase in the use of peritoneal dialysis catheters with two cuffs (51.6% vs. 36.2%, P<0.001), a Swan neck tunnel (34.1% vs. 20.9%, P<0.001), and a downward pointing exit site (34.9% vs. 29.5%, P<0.001) in patients who initiated dialysis between 1997 and 2000 compared with 1992-1996. Most hemodialysis patients continued to have an external percutaneous catheter as their access at the time of initiation of dialysis (1,550/1.971 patients, 78.6%), but the odds of using a jugular rather than a subclavian vein for these catheters increased by 24% each year between 1992 and 2000. There was a significant trend for increasing use of erythropoietin and by 1996, 96% of patients were prescribed this medication at initiation of dialysis. There was also a modest, but significant, increase in hematocrit in the dialysis registry, as the median hematocrit at 6 months of follow-up was 31% in patients who started dialysis between 1997 and 2000 (P<0.001).
KW - End-stage renal disease
KW - Hemodialysis
KW - Peritoneal dialysis
UR - http://www.scopus.com/inward/record.url?scp=0036952152&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036952152&partnerID=8YFLogxK
U2 - 10.1007/s00467-002-0928-9
DO - 10.1007/s00467-002-0928-9
M3 - Article
C2 - 12185477
AN - SCOPUS:0036952152
SN - 0931-041X
VL - 17
SP - 656
EP - 663
JO - Pediatric Nephrology
JF - Pediatric Nephrology
IS - 8
ER -